表观扩散系数变化与非小细胞肺癌立体定向放疗后局部失败相关:一项前瞻性临床试验
这项前瞻性临床研究纳入接受立体定向体部放疗(SBRT)的原发性非小细胞肺癌(NSCLC)患者,于放疗前和放疗后1个月行扩散加权MRI并构建ADC图。2例发生局部失败,且容积ADC增加>40%者局部失败比例更高。
要点
- SBRT后1个月平均单平面ADC分别增加50%和46%,容积ADC增加18%。
- 两位放射科医生单平面ADC值观察者间一致性良好(r=0.85和0.89)。
- 容积ADC增加>40%者2/2发生局部失败,低于该阈值者0/10发生局部失败。
核心结论
- SBRT后1个月ADC出现统计学显著增加,ADC增加40%与更高的局部失败率相关。
研究设计与样本
- 患者于SBRT前和完成后1个月接受MRI,序列包括T1、T2加权、增强、动态增强及扩散加权并构建ADC图。
- 由两名盲法放射科医生生成ADC值,SBRT分5次给予。
主要发现
- 两位阅片者测得平均单平面ADC分别平均增加50%和46%(P < .01,两位阅片者均如此)。
- 两位放射科医生单平面ADC值的观察者间一致性良好,Pearson相关系数基线为0.85、SBRT后1个月为0.89(两者P < .001)。
- 1个月扫描时平均容积ADC显著增加18%(Wilcoxon P = .02)。
- 2例患者在SBRT后出现局部失败,分别发生于6个月和34个月。
关键数值与推荐
- 以容积ADC增加大于40%为阈值,2/2例发生局部失败,而低于此限的0/10例发生局部失败。
临床怎么用
- SBRT后1个月行扩散加权MRI并计算ADC变化,或可作为评估治疗反应和提示局部失败的影像学指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Response assessment with computed tomography after stereotactic body radiation therapy (SBRT) for non-small cell lung cancer (NSCLC) is challenging because myriad anatomic changes can occur after treatment. Diffusion-weighted magnetic resonance imaging (MRI) may provide additional data to guide therapy response. The primary objective was to evaluate the effect of SBRT on the mean apparent diffusion coefficient (ADC). METHODS AND MATERIALS: This is a prospective clinical study of patients with NSCLC who received SBRT to the primary lung lesion. Patients underwent MRI scans before and at 1 month after completion of SBRT. MRI consisted of T1- and T2-weighted sequences, along with postcontrast, dynamic-contrast, and diffusion-weighted sequences with construction of ADC maps. Two blinded radiologists generated the ADC. SBRT was given over 5 fractions. RESULTS: A total of 13 patients were enrolled. Twelve patients were eligible for analysis. An average increase of 50% and 46% in mean single-plane ADC was observed after treatment by readers 1 and 2, respectively (P < .01, both reviewers). There was good interobserver agreement of single-plane ADC values between the 2 radiologists (Pearson correlation of 0.85 [baseline] and 0.89 [1-month post-SBRT], P < .001 for both). There was also a significant 18% increase in mean volumetric ADC on the 1-month scan (Wilcoxon P = .02). Two patients developed a local failure after SBRT, 1 at 6 months and the other at 34 months. Using a threshold of volumetric ADC increase of greater than 40%, 2 of 2 patients demonstrated local failure compared with 0 of 10 patients below this limit. CONCLUSIONS: A statistically significant increase in ADC was observed 1 month after treatment. An ADC increase of 40% at 1 month was associated with a higher rate of local failure. This pilot study provides impetus for studying ADC as a radiomic biomarker in patients receiving lung SBRT for NSCLC.
引用
- Sampath S, Rahmanuddin S, Sahoo P, et al. Change in Apparent Diffusion Coefficient Is Associated With Local Failure After Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: A Prospective Clinical Trial. Int J Radiat Oncol Biol Phys. 2019. PMID: 31271822. doi:10.1016/j.ijrobp.2019.06.2536
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。